Danaher
United States
159 articles about Danaher
-
Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases
5/12/2022
Danaher Corporation announced that it has joined the Bespoke Gene Therapy Consortium.
-
Danaher Announces Quarterly Dividends - May 10, 2022
5/10/2022
Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.25 per share of its common stock, payable on July 29, 2022 to holders of record on June 24, 2022.
-
Danaher To Present At Bank Of America Securities Health Care Conference
5/4/2022
Danaher Corporation announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 11, 2022 at 10:00 a.m. PT.
-
Danaher Announces Conversion Date For Series A Mandatory Convertible Preferred Stock
4/12/2022
Danaher Corporation announced that its 4.75% Series A Mandatory Convertible Preferred Stock, will automatically convert into shares of the Company's Common Stock on April 15, 2022.
-
Danaher Schedules First Quarter 2022 Earnings Conference Call
3/21/2022
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2022 on Thursday, April 21, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour.
-
Danaher To Present At Cowen Healthcare Conference - Mar 01, 2022
3/1/2022
Danaher Corporation announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Cowen Healthcare Conference on Tuesday, March 8, 2022 at 9:10 a.m. ET.
-
Danaher To Present At J.P. Morgan Healthcare Conference - Jan 04, 2022
1/4/2022
Danaher Corporation announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 11:15 a.m. ET.
-
Danaher Announces Pricing Of Senior Notes Offering - Dec 02, 2021
12/2/2021
Danaher Corporation announced that it has priced an offering of $1,000,000,000 principal amount of 2.800% senior notes due 2051 at an offering price of 99.396% of the principal amount.
-
Danaher Announces Redemption Of Senior Notes - Nov 29, 2021
11/29/2021
Danaher Corporation announced that it will redeem all of the €800,000,000 aggregate principal amount of 2.500% Senior Notes due 2025 issued by DH Europe Finance S.À R.L. and guaranteed by Danaher, at a redemption price equal to the outstanding principal amount and a make-whole premium as specified in the indenture governing the Notes, plus accrued and unpaid interest.
-
Danaher Reports Third Quarter 2021 Results
10/21/2021
Danaher Corporation announced results for the third quarter 2021. All results in this release reflect only continuing operations unless otherwise noted.
-
Danaher Schedules Third Quarter 2021 Earnings Conference Call
9/21/2021
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2021 on Thursday, October 21, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour.
-
Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions
7/27/2021
An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher Corporation, will expand manufacturing capacity and services across geographies for global life sciences customers.
-
Danaher Reports Second Quarter 2021 Results
7/22/2021
Danaher Corporation announced results for the second quarter 2021. All results in this release reflect only continuing operations unless otherwise noted.
-
Danaher Schedules Second Quarter 2021 Earnings Conference Call
6/22/2021
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2021 on Thursday, July 22, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour.
-
Danaher To Present At Goldman Sachs Global Healthcare Conference
6/7/2021
Danaher Corporation announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Goldman Sachs Global Healthcare Conference on Tuesday, June 8, 2021 at 2:10 p.m. ET.
-
Danaher Announces Appointment of A. Shane Sanders to Danaher Board
5/13/2021
Danaher Corporation announced that it has appointed A. Shane Sanders to its Board of Directors and to its Audit Committee.
-
Danaher To Present At Bank Of America Healthcare Conference
5/4/2021
Danaher Corporation announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Healthcare Conference on Tuesday, May 11, 2021 at 2:00 p.m. ET.
-
Danaher Announces Renowned Scientists To Join New Scientific Advisory Board
4/26/2021
DIVERSE SCIENTIFIC EXPERTISE AND PROPRIETARY INSIGHTS WILL SUPPORT COMPANY GROWTH AND IMPACT
-
Danaher Provides Update On First Quarter 2021 Financial Performance
4/13/2021
Danaher Corporation (NYSE: DHR) (the "Company") announced today that it expects first quarter 2021 core revenue growth to be above the high-end of the Company's previously communicated guidance range. For the quarter ended April 2, 2021 , the Company expects revenue growth to be approximately 57.0% and non-GAAP core revenue growth
-
Danaher To Present At Barclays Global Healthcare Conference
3/4/2021
Danaher Corporation announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 11:30 a.m. ET.